Avior Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22
| Closed | -$3K | – | 1756 |
|
|
2024
Q4 | $3K | Buy |
+22
| New | +$3K | ﹤0.01% | 2033 |
|
|
2024
Q3 | – | Sell |
-3,360
| Closed | -$463K | – | 2383 |
|
|
2024
Q2 | $463K | Sell |
3,360
-824
| -20% | -$113K | 0.02% | 455 |
|
|
2024
Q1 | $577K | Sell |
4,184
-43
| -1% | -$5.93K | 0.03% | 404 |
|
|
2023
Q4 | $557K | Sell |
4,227
-282
| -6% | -$37.2K | 0.03% | 319 |
|
|
2023
Q3 | $507K | Buy |
4,509
+1,924
| +74% | +$216K | 0.03% | 326 |
|
|
2023
Q2 | $244K | Buy |
2,585
+414
| +19% | +$39K | 0.02% | 488 |
|
|
2023
Q1 | $220K | Sell |
2,171
-111
| -5% | -$11.2K | 0.02% | 513 |
|
|
2022
Q4 | $273K | Sell |
2,282
-1,602
| -41% | -$191K | 0.02% | 419 |
|
|
2022
Q3 | $412K | Sell |
3,884
-561
| -13% | -$59.5K | 0.03% | 314 |
|
|
2022
Q2 | $433K | Sell |
4,445
-1,387
| -24% | -$135K | 0.04% | 277 |
|
|
2022
Q1 | $546K | Sell |
5,832
-3,139
| -35% | -$294K | 0.05% | 280 |
|
|
2021
Q4 | $764K | Buy |
8,971
+835
| +10% | +$71.1K | 0.06% | 243 |
|
|
2021
Q3 | $780K | Buy |
8,136
+1,035
| +15% | +$99.2K | 0.06% | 225 |
|
|
2021
Q2 | $691K | Buy |
7,101
+71
| +1% | +$6.91K | 0.07% | 232 |
|
|
2021
Q1 | $683K | Buy |
7,030
+915
| +15% | +$88.9K | 0.07% | 231 |
|
|
2020
Q4 | $586K | Buy |
6,115
+860
| +16% | +$82.4K | 0.07% | 234 |
|
|
2020
Q3 | $504K | Buy |
5,255
+450
| +9% | +$43.2K | 0.07% | 232 |
|
|
2020
Q2 | $585K | Buy |
4,805
+100
| +2% | +$12.2K | 0.09% | 203 |
|
|
2020
Q1 | $406K | Buy |
4,705
+4,660
| +10,356% | +$402K | 0.08% | 227 |
|
|
2019
Q4 | $4K | Buy |
+45
| New | +$4K | ﹤0.01% | 670 |
|
|
2019
Q2 | – | Sell |
-3,030
| Closed | -$266K | – | 860 |
|
|
2019
Q1 | $266K | Buy |
3,030
+910
| +43% | +$79.9K | 0.06% | 302 |
|
|
2018
Q4 | $151K | Buy |
2,120
+910
| +75% | +$64.8K | 0.04% | 372 |
|
|
2018
Q3 | $149K | Sell |
1,210
-1,279
| -51% | -$157K | 0.03% | 402 |
|
|
2018
Q2 | $245K | Buy |
2,489
+1,258
| +102% | +$124K | 0.06% | 278 |
|
|
2018
Q1 | $102K | Buy |
1,231
+111
| +10% | +$9.2K | 0.02% | 439 |
|
|
2017
Q4 | $87K | Buy |
+1,120
| New | +$87K | 0.02% | 451 |
|